PRESS INFORMATION
Heading: 1st half 2016 results
Nanterre, September 7, 2016

1st half 2016 operating profit stands at 8.6%

Accounts at June 30 (audited in € millions) H1 2016 H1 2015 2015
Revenues  221.5 195.5 399.4
Business operating profit (*)   19.5 (8.8%)   17.2 (8.8%)   37.6 (9.4%)
Operating profit   19.1 (8.6%)   16.8 (8.6%)   37.1 (9.3%)
Net financial profit   0.6   0.9   1.4
Corporate income tax   (7.1)   (6.5)  (14.0)
Net profit after tax   12.6 (5.7%)   11.2 (5.7%)   24.5 (6.1%)
  of which, group share   10.9   9.7   21.3
Staff at end of period  4,865 4,377 4,580

(*) Prior to cost of bonus shares and impairment of assets.

Achievements

The Group posted sustained growth in the first half (+13.3% including +10% at a constant scope of consolidation).

Operating profit increased by 13.5% and stood at 8.6% of revenues.

The Group's net cash amounted to €119.7m on June 30, 2016.

Outlook

Overall, for 2016, NEURONES maintains its forecast to achieve annual revenues of €440 million and an operating profit of around 9%.

About NEURONES

With over 4,800 experts, the NEURONES group specializes in Consulting (Management, Organization and Digital) and IT Services (Infrastructures and Applications). It supports its clients in their change-management projects and in the upgrading and outsourcing of their Information Systems.

Euronext Paris (compartment B - NRO) - Enternext Tech 40 - PEA-PME eligible - SRD medium values

www.neurones.net

Press Relations:
Florence Gillier  Communication
Sabine Grosdidier
Tel.: +33 (0)1 41 18 85 55
sabineg@fgcom.fr
 

NEURONES
Matthieu Vautier
Tel.: +33 (0)1 41 37 41 37
rp@neurones.net
Investor relations:
NEURONES
Paul-César Bonnel
Tel.: +33 (0)1 41 37 41 37
investisseurs@neurones.net
 
NEURONES - H1 2016 results



This announcement is distributed by Nasdaq Corporate Solutions on behalf of Nasdaq Corporate Solutions clients.
The issuer of this announcement warrants that they are solely responsible for the content, accuracy and originality of the information contained therein.
Source: NEURONES via Globenewswire